Practice
Featured experience
InSilico Medicine HK$2.62 billion IPO
We advised InSilico Medicine on its IPO and HKEX listing
Mastercard $1.8 billion acquisition of BVNK
We are advising Mastercard on the transaction
Sycamore Partners up to $23.7 billion acquisition of Walgreens Boots Alliance
We advised Sycamore Partners on the transaction
Comcast spinoff of select cable television networks
We are advising Comcast on the transaction
Vale R$11.5 billion participating debentures
We advised the placement agents on the offering
Alkami Technology $207 million IPO
We advised the underwriters on the IPO and Nasdaq listing
Americo Life $400 million senior notes offering
We advised the initial purchasers on the investment-grade notes offering
EnVen Energy $300 million high-yield notes offering and credit facility amendment
We advised EnVen on its senior secured notes offering and credit facility
Ultra Clean $175 million follow-on offering
We advised Ultra Clean on its SEC-registered equity offering
Diagnósticos da América R$3.3 billion equity offering
We advised the global coordinators and joint bookrunners on the Rule 144A / Regulation S offering
Ionis Pharmaceuticals $632.5 million convertible senior notes offering
We advised the purchasers on the Rule 144A convertible notes offering
Maravai LifeSciences $646.9 million secondary offering
We advised the joint book-running managers on the equity offering
Marvell Technology $2 billion senior notes offering
We advised the initial purchasers on the unregistered debt offering
PPC $1 billion sustainability-linked senior notes offering
We advised the initial purchasers on the Rule 144A / Regulation S offering